Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA)

Clinical and Experimental Immunology

Volumn 148, Issue 3, 2007, Pages 515-519

  Aggarwal, A ^a   Agarwal, S ^a   Misra, R ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chemokine receptors; Chemokines; Homing receptors; Inflammation

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; METHOTREXATE; RANTES;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENTHESITIS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE MIGRATION; LYMPHOCYTE HOMING; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SYNOVIAL FLUID; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; ARTHRITIS; ARTHRITIS, JUVENILE RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CHEMOKINES, CC; CHEMOKINES, CXC; CHILD; FEMALE; HUMANS; MALE; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; SYNOVIAL FLUID; T-LYMPHOCYTE SUBSETS;

EID: 34247875977     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03377.x     Document Type: Article

References (21)

1. Charo IF, Ranshoff RM. The many roles of chemokines and chemokine receptors in inflammation. New Engl J Med 2006 354:610 21.
2. Loetscher P, Uguccioni M, Bordoli L et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998 391:344 5.
3. Yang YF, Mukai T, Gao P et al. A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses. Eur J Immunol 2002 32:2124 32.
4. Vierboom MP, Zavodny PJ, Chou CC et al. Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5. Arthritis Rheum 2005 52:627 36.
5. Okamoto H, Kamatani N. A CCR-5 antagonist inhibits the development of adjuvant arthritis in rats. Rheumatol (Oxf) 2006 45:230 2.
6. Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K. Selective accumulation of CCR5-T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999 11:553 9.
7. Patel DD, Zachariah JP, Whichard LP. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol 2001 98:39 45.
8. Wedderburn LR, Robinson N, Patel A, Varsani H, Woo P. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2000 43:765 74.
9. Thompson SD, Luyrink LK, Graham TB et al. Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol 2001 166:6899 906.
10. Martini G, Zulian F, Calabrese F et al. CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis. Arthritis Res Ther 2005 7:R241 9.
11. Aggarwal A, Misra R. Juvenile chronic arthritis in India: is it different from that seen in western countries? Rheumatol Int 1994 14:53 6.
12. Flato B, Hoffmann-Vold A, Reiff A, Forre O, Lien G, Vinje O. Long term outcome and prognostic factors in enthesitis related arthritis. A case-control study. Arthritis Rheum 2006 54:3573 82.
13. Murray KJ, Luyrink L, Grom AA et al. Immunohistological characteristics of T cell infiltrate in different form of childhood onset chronic arthritis. J Rheumatol 1996 23:2116 24.
14. Petty RE, Southwood TR, Baum J et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis; Durban, 1997. J Rheumatol 1998 25:1991 4.
15. Saxena N, Aggarwal A, Misra R. Elevated levels of monocyte derived cytokine in synovial fluid of children with ERA and polyarticular form of juvenile idiopathic arthritis. J Rheumatol 2005 32:1349 53.
16. Haringman JJ, Smeets TJ, Reinders-Blankert P, Tak PP. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 2006 65:294 30.
17. Okamoto H, Koizumi K, Yamanaka H, Saito T, Kamatani N. A role of TARC/CCL17, a CC chemokine, in systemic lupus erythematosus. J Rheumatol 2003 30:2369 73.
18. Pharoah DS, Varsani H, Tatham RW et al. Expression of inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells. Arthritis Res Ther 2006 8:R50.
19. Yang PT, Kasai H, Zhao LJ, Xiao WG, Tanabe F, Ito M. Increased CCR4 expression on circulating CD4+T lymphocytes in patients with ankylosing spondylitis and systemic lupus erythematosus. Clin Exp Immunol 2004 138:342 7.
20. Gattorno M, Progione I, Morandi F et al. Phenotypic and functional characterization of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis. Arthritis Res Ther 2005 7:R256 R267.
21. Salomon I, Netzer N, Wildbaum G, Schif-Zuck S, Maor G, Karin N. Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis. J Immunol 2002 169:2685 93.